Tarceva (erlotinib) is an oral anti-cancer drug under development by OSI Pharmaceuticals, Genentech and Roche.
-
Tarceva (erlotinib) is an oral anti-cancer drug under development by OSI... -
Over expression of EGFR is common in many solid tumours. (Source: ABPI) -
Tarceva works by inhibiting receptor tyrosine kinase activity, the protein... -
Roche R&D Centre, Basle.
